查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球医用加湿器市场按产品、应用、分销管道、患者类型、最终用户和地区划分 - 预测至 2029 年
市场调查报告书
商品编码
1681002

全球医用加湿器市场按产品、应用、分销管道、患者类型、最终用户和地区划分 - 预测至 2029 年

Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs, Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 294 Pages | 订单完成后即时交付

价格

全球医用加湿器市场规模预计将从 2024 年的 9.228 亿美元增至 2029 年的 12.117 亿美元，预测期内的复合年增长率为 5.6%。

原因包括：慢性阻塞性肺病、气喘、睡眠呼吸中止症、肺炎和支气管炎患者数量的增加；空气污染、吸烟和气候变迁造成的呼吸系统疾病的恶化；新生儿加护病房（NICU）中新生儿和婴儿（特别是早产儿）需要湿化氧气疗法；以及由于人口老龄化和医疗成本上升而转向家庭护理。然而，定期的维护、更换零件（过滤器、腔室）和能源消耗的费用增加了经济负担，而维护不善和清洁不当会导致细菌和霉菌的生长，增加感染的风险。

研究范围
调查年份 2022-2029
基准年 2023
预测期 2023-2029
考虑单位 金额（百万美元）
部分 按产品、按应用、按分销管道、按患者类型、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲、海湾合作委员会国家

医用加湿器市场按产品细分为加热加湿器、气泡加湿器、热湿交换器 (HME) 和加湿器配件。其中，加热加湿器将在2023年占据医用加湿器市场最大的市场占有率。这是因为在机械通气、氧气疗法和非侵入性通气（NIV）中越来越多地使用加热加湿器来防止呼吸道干燥和炎症，老年人口的不断增长使他们更容易患上呼吸系统疾病，而且美国食品药物管理局（FDA）和欧洲合格评定委员会（CE）（欧洲）等全球机构的监管支持确保了产品质量并增强了市场信心。

根据应用，医疗加湿器市场分为加护病房(ICU)、新生儿护理、呼吸治疗和其他应用。加护病房（ICU）占据了医用加湿器市场最大的市场份额，这是由于严重呼吸系统疾病、肺炎和术后恢復导致的住院人数增加，新生儿重症加护病房（NICU）中需要湿化氧气进行市场占有率支持的早产儿，以及公共和私人医疗保健对扩大ICU容量的投资，都增加了加湿器的采用。此外，疫情凸显了机械通气病人对先进的ICU加湿系统的需求。

全球医用加湿器市场分为六大区域：北美、欧洲、亚太、拉丁美洲、中东和非洲、海湾合作委员会国家。预计在估计和预测期内，亚太地区将以最高的复合年增长率成长。这是由于人口老化和在家中管理慢性病造成的。日本、韩国和中国等高龄化社会更容易出现呼吸系统疾病并需要进入ICU。中国、印度、日本和东南亚各国政府正在投资扩建重症监护室，以改善重症加护。低出生体重和早产儿常有呼吸问题，需要湿化氧气疗法。经合组织预计，2022年亚太中低收入国家平均新生儿死亡率将达到每1,000名活产婴儿中15.6名死亡。日本、中国、印度、澳洲和其他地区构成了该地区。 2023年中国将在医用加湿器市场占据最高市场占有率。这是由于中国人口老化、认识不断提高、医疗设施投入增加以及慢性阻塞性肺病和气喘等呼吸系统疾病的发生率不断上升。中国是全球老化最快的国家，预计年终60岁以上人口将超过2.8亿，占总人口的19.8%。

本报告研究了全球医用加湿器市场，并根据产品、应用、分销管道、患者类型、最终用户、区域趋势和公司概况对市场进行了详细的分析。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 定价分析
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 监管状态
  • 专利分析
  • 贸易分析
  • 2025-2026 年重要会议与活动
  • 影响客户业务的趋势/干扰
  • 技术分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 投资金筹措场景
  • 人工智慧/生成式人工智慧对医用加湿器市场的影响

第六章 医用加湿器市场（依产品）

  • 介绍
  • 加热加湿器
  • 热湿交换器
  • 气泡加湿器
  • 加湿器配件

第七章 医用加湿器市场（依应用）

  • 介绍
  • 加护病房
  • 新生儿护理
  • 呼吸治疗
  • 其他的

第 8 章 医用加湿器市场（通路）

  • 介绍
  • 院内药房
  • 零售药局
  • 网路药局

第九章 医用加湿器市场（依病患型态）

  • 介绍
  • 成年患者
  • 新生儿患者
  • 儿科患者

第 10 章 医用加湿器市场（按最终用户）

  • 介绍
  • 医院及门诊手术中心
  • 居家照护
  • 专科门诊
  • 其他的

第十一章 医用加湿器市场（按区域）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太地区：宏观经济展望
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 其他的
  • 拉丁美洲
  • 中东和非洲
  • 海湾合作委员会国家

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势，2022-2025 年
  • 主要参与企业所采用的策略概述
  • 2021-2023 年收益分析
  • 2023 年市场占有率分析
  • 企业市场占有率按产品分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 品牌/产品比较
  • 竞争场景

第十三章 公司简介

  • 主要参与企业
    • FISHER & PAYKEL HEALTHCARE LIMITED
    • RESMED INC.
    • DRAGERWERK AG & CO. KGAA
    • KONINKLIJKE PHILIPS NV
    • VINCENT MEDICAL HOLDINGS LIMITED
    • MEDLINE INDUSTRIES, LP.
    • HAMILTON MEDICAL
    • GALEMED CORPORATION
    • EAKIN HEALTHCARE
  • 其他公司
    • VADI MEDICAL TECHNOLOGY CO., LTD.
    • SHENYANG RMS MEDICAL TECH CO., LTD
    • FLEXICARE（GROUP）LIMITED
    • BESMED HEALTH BUSINESS CORP
    • LOWENSTEIN MEDICAL SE & CO. KG
    • INTERSURGICAL
    • PRECISION MEDICAL, INC.
    • DRIVE DEVILBISS INTERNATIONAL
    • NEOKRAFT MEDICAL PVT. LTD.
    • DYNAREX CORPORATION
    • HSI LLC.
    • TRUDELL MEDICAL LIMITED
    • GREAT GROUP MEDICAL CO., LTD.
    • FANEM
    • HEYER MEDICAL AG
    • BIOSYS

第十四章 附录

Product Code: MD 9325

The global Medical humidifier market is projected to reach USD 1,211.7 million by 2029 from USD 922.8 million in 2024, at a CAGR of 5.6% during the forecast period. This is due to increasing cases of COPD, asthma, sleep apnea, pneumonia, and bronchitis, growing air pollution, smoking, and climate change are worsening respiratory conditions, necessitating humidification therapy, newborns and infants, especially premature babies, require humidified oxygen therapy in neonatal intensive care units (NICUs), and aging populations and rising healthcare costs are driving a shift toward home-based treatments. But recurring costs for maintenance, replacement parts (filters, chambers), and energy consumption add to financial burden, and poor maintenance or improper cleaning can lead to bacterial and mold growth, increasing infection risks.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2023-2029
Units ConsideredValue (USD million)
SegmentsProduct, Application, Distribution Channel, Patient type, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA, GCC Countries

"The heated humidifier segment of medical humidifier market by product to hold largest market share during forecast period."

Based on the product, the medical humidifier market is divided into Heated Humidifier, Bubble Humidifier , Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among these, in 2023 heated humidifier segment account for the largest market share of in medical humidifier market. This is due to the increasing use of Heated humidifiers in mechanical ventilation, oxygen therapy, and non-invasive ventilation (NIV) to prevent airway dryness and irritation, rising geriatric population who are more prone to respiratory conditions, and regulatory support from the US Food and Drug Administration (FDA), Conformite Europeene (CE) (Europe), and other global bodies ensures product quality and drives market confidence.

"The intensive care unit (ICU) segment of medical humidifier market by application to hold largest market share during the forecast period."

Based on application, the medical humidifier market is segmented into Intensive Care Unit (ICU), Neonatal Care, Respiratory Therapy, and Other Applications. The intensive care unit (ICU) segment accounts for the largest market share in medical humidifier market due to increasing hospitalizations due to severe respiratory diseases, pneumonia, and post-surgical recovery, premature infants require respiratory support with humidified oxygen in neonatal intensive care units (NICUs), and public and private healthcare investments in ICU capacity expansion are increasing humidifier adoption. Moreover, The pandemic highlighted the need for advanced ICU humidification systems for ventilated patients.

"Asia Pacific to hold the highest CAGR of the medical humidifier market by region."

The global medical humidifier market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is attributed to an aging population and chronic disease management at home. Japan, South Korea, and China's aging populations are more likely to develop respiratory problems and require ICU admissions. The governments of China, India, Japan, and Southeast Asia are investing in ICU growth to improve critical care. Low-birth-weight and premature babies often suffer with respiratory problems and need humidified oxygen therapy. The OECD estimates that the average neonatal mortality rate in lower-middle- and low-income APAC countries in 2022 will be 15.6 deaths per 1,000 live births. Japan, China, India, Australia, and the rest of Asia Pacific comprise the region. In the medical humidifier market in 2023 China boasts the highest market share. This is ascribed to China's aging population, rising awareness, investments in healthcare facilities, and rising frequency of respiratory diseases including COPD and asthma. With more than 280 million individuals aged 60 and above as of the end of 2022, or 19.8% of the whole population, China has the highest aging population worldwide.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-46%, and Tier 3- 24%
  • By Designation: C-level-25%, Director-level-35% and Others-40%
  • By Region: North America-40%, Europe-25%, Asia Pacific-19%, Latin America- 8%, Middle east and Africa - 6%, and GCC Countries - 2 %

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1.0 billion, Tier 2 = USD 500.0 million to USD 1.0 billion, and Tier 3 = <USD 500.0 million.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the medical humidifier market are include ResMed Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan), and Eakin Healthcare (UK).

Research Coverage

This report studies the medical humidifier market based on product, application, distribution channel, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers (Rising use of medical humidifiers in ventilation therapy, Increasing prevalence of respiratory diseases, Rising incidence of premature births and advances in neonatal care, Rapid growth in geriatric population), restraints (Frequent replacement of disposable components, increasing operational costs, Low awareness of the threat of respiratory diseases), Challenge (Risk of infectious due to improper maintenance, High cost of advanced humidifiers to limit adoption), opportunity (Post-pandemic demand for respiratory care, Government and non-government initiatives in respiratory health, Increasing investments in hospital infrastructure in emerging markets)
  • Market Penetration: Complete knowledge on the spectrum of products presented by the major companies in the medical humidifier market
  • Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and new products introductions within the medical humidifier market
  • Market Development: Complete knowledge about profitable developing regions
  • Market Diversification: Exhaustive knowledge on new goods, expanding geographies, and current changes in the medical humidifier industry helps to diversify the market
  • Competitive Assessment: Comprehensive evaluation of market segmentation, development plans, income analysis, and goods of the top market participants.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
    • 1.4.1 IMPACT OF AI/GENERATIVE AI

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Growth forecast
      • 2.2.1.4 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ASSESSMENT
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 STUDY LIMITATIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 MEDICAL HUMIDIFIER MARKET OVERVIEW
  • 4.2 ASIA PACIFIC MEDICAL HUMIDIFIER MARKET SHARE, BY APPLICATION AND COUNTRY
  • 4.3 MEDICAL HUMIDIFIER MARKET, BY COUNTRY
  • 4.4 MEDICAL HUMIDIFIER MARKET, REGIONAL MIX, 2024 VS. 2029
  • 4.5 MEDICAL HUMIDIFIER MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising use of medical humidifiers in ventilation therapy
      • 5.2.1.2 Increasing prevalence of respiratory diseases
      • 5.2.1.3 Rising incidence of premature births and advances in neonatal care
      • 5.2.1.4 Rapid growth in geriatric population
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Frequent replacement of disposable components, increasing operational costs
      • 5.2.2.2 Low awareness of threat of respiratory diseases
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Post-pandemic demand for respiratory care
      • 5.2.3.2 Government and non-government initiatives in respiratory health
      • 5.2.3.3 Increasing investments in hospital infrastructure in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Risk of infections due to improper maintenance
      • 5.2.4.2 High cost of advanced humidifiers to limit adoption
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
    • 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & DEVELOPMENT (R&D)
    • 5.4.2 MANUFACTURING
    • 5.4.3 DISTRIBUTION AND MARKETING & SALES
    • 5.4.4 POST-SALES SERVICES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • 5.5.1 PROMINENT COMPANIES
    • 5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.5.3 END USERS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.2 REGULATORY FRAMEWORK
      • 5.7.2.1 North America
        • 5.7.2.1.1 US
        • 5.7.2.1.2 Canada
      • 5.7.2.2 Europe
      • 5.7.2.3 Asia Pacific
        • 5.7.2.3.1 China
        • 5.7.2.3.2 Japan
        • 5.7.2.3.3 India
      • 5.7.2.4 Latin America
        • 5.7.2.4.1 Brazil
  • 5.8 PATENT ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 IMPORT DATA FOR HS CODE 901920
    • 5.9.2 EXPORT DATA FOR HS CODE 901920
  • 5.10 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12 TECHNOLOGY ANALYSIS
    • 5.12.1 KEY TECHNOLOGIES
      • 5.12.1.1 Heating technology
    • 5.12.2 COMPLEMENTARY TECHNOLOGIES
      • 5.12.2.1 Bubble diffusion technology
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF SUPPLIERS
    • 5.13.4 BARGAINING POWER OF BUYERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GENERATIVE AI ON MEDICAL HUMIDIFIER MARKET
    • 5.16.1 INTRODUCTION
    • 5.16.2 AI USE CASES
    • 5.16.3 AI IN MEDICAL HUMIDIFIERS

6 MEDICAL HUMIDIFIER MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 HEATED HUMIDIFIERS
    • 6.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
  • 6.3 HEAT & MOISTURE EXCHANGERS
    • 6.3.1 RISING DEMAND FOR COST-EFFECTIVE AND DISPOSABLE HMES TO DRIVE MARKET
  • 6.4 BUBBLE HUMIDIFIERS
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN HUMIDIFICATION SYSTEMS TO PROPEL MARKET GROWTH
  • 6.5 HUMIDIFIER ACCESSORIES
    • 6.5.1 INCREASED REPLACEMENT FREQUENCY OF ACCESSORIES TO FUEL DEMAND

7 MEDICAL HUMIDIFIER MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 INTENSIVE CARE UNITS
    • 7.2.1 INCREASE IN ICU ADMISSIONS TO DRIVE MARKET GROWTH
  • 7.3 NEONATAL CARE
    • 7.3.1 RISING PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO DRIVE MARKET
  • 7.4 RESPIRATORY THERAPY
    • 7.4.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE DEMAND
  • 7.5 OTHER APPLICATIONS

8 MEDICAL HUMIDIFIER MARKET, DISTRIBUTION CHANNEL

  • 8.1 INTRODUCTION
  • 8.2 HOSPITAL PHARMACIES
    • 8.2.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS AND BULK PURCHASES OF MEDICAL HUMIDIFIERS TO DRIVE MARKET
  • 8.3 RETAIL PHARMACIES
    • 8.3.1 RISING DEMAND FOR HOME-BASED RESPIRATORY CARE SOLUTIONS TO DRIVE MARKET
  • 8.4 ONLINE PHARMACIES
    • 8.4.1 RISE IN E-COMMERCE ADOPTION AND DIGITAL TRANSFORMATION IN HEALTHCARE TO SUPPORT MARKET GROWTH

9 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE

  • 9.1 INTRODUCTION
  • 9.2 ADULT PATIENTS
    • 9.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE THE MARKET
  • 9.3 NEONATAL PATIENTS
    • 9.3.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL MARKET GROWTH
  • 9.4 PEDIATRIC PATIENTS
    • 9.4.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL GROWTH

10 MEDICAL HUMIDIFIER MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
    • 10.2.1 RISING NUMBER OF ICU ADMISSIONS AND PREFERENCE FOR AMBULATORY SURGERY TO DRIVE DEMAND
  • 10.3 HOME CARE SETTINGS
    • 10.3.1 RISING ELDERLY POPULATION TO DRIVE DEMAND FOR HOME-USE DEVICES
  • 10.4 SPECIALTY CLINICS
    • 10.4.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET
  • 10.5 OTHER END USERS

11 MEDICAL HUMIDIFIER MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Rising premature births and advances in neonatal care to drive market
    • 11.2.3 CANADA
      • 11.2.3.1 Increasing prevalence of respiratory diseases to drive market
  • 11.3 EUROPE
    • 11.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 11.3.2 GERMANY
      • 11.3.2.1 Increasing public healthcare expenditure to foster market growth
    • 11.3.3 UK
      • 11.3.3.1 Increasing incidence of respiratory conditions such as COPD and asthma to drive market
    • 11.3.4 FRANCE
      • 11.3.4.1 High prevalence of COPD to surge demand
    • 11.3.5 ITALY
      • 11.3.5.1 Increasing geriatric population to support demand for humidifiers
    • 11.3.6 SPAIN
      • 11.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 11.4.2 CHINA
      • 11.4.2.1 Growing elderly demographic to propel market
    • 11.4.3 JAPAN
      • 11.4.3.1 High prevalence of respiratory diseases to drive market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Expanding healthcare infrastructure to drive demand
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 High prevalence of COPD & asthma to drive market growth
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 HIGH NEONATAL MORTALITY RATE TO DRIVE MARKET
    • 11.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
    • 11.6.2 MIDDLE EAST &AFRICA: MACROECONOMIC OUTLOOK
  • 11.7 GCC COUNTRIES
    • 11.7.1 SIGNIFICANT INVESTMENTS IN DEVELOPMENT AND EXPANSION OF HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • 11.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
  • 12.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.4 REVENUE ANALYSIS, 2021-2023
  • 12.5 MARKET SHARE ANALYSIS, 2023
    • 12.5.1 RANKING OF KEY MARKET PLAYERS
  • 12.6 COMPANY SHARE ANALYSIS, BY PRODUCT
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Region footprint
      • 12.7.5.3 Product footprint
      • 12.7.5.4 Application footprint
      • 12.7.5.5 End-user footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key emerging players/startups
  • 12.9 COMPANY VALUATION & FINANCIAL METRICS
    • 12.9.1 FINANCIAL METRICS
    • 12.9.2 COMPANY VALUATION
  • 12.10 BRAND/PRODUCT COMPARISON
  • 12.11 COMPETITIVE SCENARIO
    • 12.11.1 PRODUCT LAUNCHES
    • 12.11.2 DEALS
    • 12.11.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 FISHER & PAYKEL HEALTHCARE LIMITED
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices made
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 RESMED INC.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 MnM view
        • 13.1.2.3.1 Key strengths
        • 13.1.2.3.2 Strategic choices made
        • 13.1.2.3.3 Weaknesses and competitive threats
    • 13.1.3 DRAGERWERK AG & CO. KGAA
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 MnM view
        • 13.1.3.3.1 Key strengths
        • 13.1.3.3.2 Strategic choices made
        • 13.1.3.3.3 Weaknesses and competitive threats
    • 13.1.4 KONINKLIJKE PHILIPS N.V.
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
    • 13.1.5 VINCENT MEDICAL HOLDINGS LIMITED
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Expansions
    • 13.1.6 MEDLINE INDUSTRIES, LP.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Deals
        • 13.1.6.3.2 Expansions
    • 13.1.7 HAMILTON MEDICAL
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Expansions
    • 13.1.8 GALEMED CORPORATION
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
    • 13.1.9 EAKIN HEALTHCARE
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 VADI MEDICAL TECHNOLOGY CO., LTD.
    • 13.2.2 SHENYANG RMS MEDICAL TECH CO., LTD
    • 13.2.3 FLEXICARE (GROUP) LIMITED
    • 13.2.4 BESMED HEALTH BUSINESS CORP
    • 13.2.5 LOWENSTEIN MEDICAL SE & CO. KG
    • 13.2.6 INTERSURGICAL
    • 13.2.7 PRECISION MEDICAL, INC.
    • 13.2.8 DRIVE DEVILBISS INTERNATIONAL
    • 13.2.9 NEOKRAFT MEDICAL PVT. LTD.
    • 13.2.10 DYNAREX CORPORATION
    • 13.2.11 HSI LLC.
    • 13.2.12 TRUDELL MEDICAL LIMITED
    • 13.2.13 GREAT GROUP MEDICAL CO., LTD.
    • 13.2.14 FANEM
    • 13.2.15 HEYER MEDICAL AG
    • 13.2.16 BIOSYS

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 RISK ASSESSMENT: MEDICAL HUMIDIFIER MARKET
  • TABLE 2 US: MORTALITY RATE OF RESPIRATORY DISORDERS
  • TABLE 3 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023-2025 (USD)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TYPE, 2023-2025
  • TABLE 6 MEDICAL HUMIDIFIER MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 ISO: INTEGRATION WITH OTHER EQUIPMENT
  • TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 18 MEDICAL HUMIDIFIER MARKET: INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2022- FEBRUARY 2025
  • TABLE 19 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 20 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 21 MEDICAL HUMIDIFIER MARKET: KEY CONFERENCES & EVENTS, 2025-2026
  • TABLE 22 MEDICAL HUMIDIFIER MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER (%)
  • TABLE 24 KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER
  • TABLE 25 MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 26 KEY HEATED HUMIDIFIERS OFFERED, BY COMPANY
  • TABLE 27 HEATED HUMIDIFIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 HEATED HUMIDIFIER MARKET, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 29 NORTH AMERICA: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 EUROPE: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 KEY HEAT & MOISTURE EXCHANGERS OFFERED, BY COMPANY
  • TABLE 33 HEAT & MOISTURE EXCHANGERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 EUROPE: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 KEY BUBBLE HUMIDIFIERS OFFERED, BY COMPANY
  • TABLE 38 BUBBLE HUMIDIFIERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 EUROPE: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 KEY HUMIDIFIER ACCESSORIES OFFERED, BY COMPANY
  • TABLE 43 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 48 NUMBER OF ICU BEDS, BY COUNTRY (2024)
  • TABLE 49 MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 EUROPE: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 NEONATAL MORTALITY RATES, BY COUNTRY (2022)
  • TABLE 54 MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 EUROPE: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 67 MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 EUROPE: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 NUMBER OF NEONATAL DEATHS (2022)
  • TABLE 85 MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 94 MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 EUROPE: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 MEDICAL HUMIDIFIER MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 112 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 118 US: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 119 US: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 120 US: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 121 US: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 US: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 123 CANADA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 124 CANADA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 125 CANADA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 126 CANADA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 CANADA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 128 EUROPE: KEY MACROINDICATORS
  • TABLE 129 EUROPE: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 132 EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 133 EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 135 GERMANY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 136 GERMANY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 137 GERMANY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 138 GERMANY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 GERMANY: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 140 UK: MORTALITY FROM RESPIRATORY DISEASE, 2018-2023 (ALL AGES)
  • TABLE 141 UK: NUMBER OF PEOPLE RECEIVING DOMICILIARY CARE (HOME CARE) BY NATION
  • TABLE 142 UK: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 143 UK: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 144 UK: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 145 UK: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 UK: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 147 FRANCE: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST, BY TYPE (2021)
  • TABLE 148 FRANCE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 149 FRANCE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 150 FRANCE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 151 FRANCE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 FRANCE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 153 ITALY: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST, BY TYPE (2021)
  • TABLE 154 ITALY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 155 ITALY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 156 ITALY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 157 ITALY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 ITALY: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 159 SPAIN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 160 SPAIN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 161 SPAIN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 162 SPAIN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 SPAIN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 164 REST OF EUROPE: MORTALITY RATE OF RESPIRATORY DISEASES (2021)
  • TABLE 165 REST OF EUROPE: NEONATE MORTALITY RATE (2022)
  • TABLE 166 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 167 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 168 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 169 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 171 ASIA & PACIFIC: KEY MACROINDICATORS
  • TABLE 172 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 178 CHINA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 179 CHINA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 180 CHINA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 181 CHINA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 CHINA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 183 JAPAN: LEADING CAUSES OF DEATH (2021)
  • TABLE 184 JAPAN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 JAPAN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 186 JAPAN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 187 JAPAN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 JAPAN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 189 INDIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 190 INDIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 191 INDIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 192 INDIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 INDIA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 194 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 195 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 196 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 197 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: MORTALITY IN CHILDREN UNDER 5 YEARS (2022)
  • TABLE 200 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 201 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 202 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 203 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 205 LATIN AMERICA: NEONATAL MORTALITY RATE (2022)
  • TABLE 206 LATIN AMERICA & CARIBBEAN: KEY MACROINDICATORS
  • TABLE 207 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 208 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 210 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 212 MIDDLE EAST & AFRICA: NEONATAL MORTALITY RATE (2022)
  • TABLE 213 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 214 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 219 GCC COUNTRIES: NEONATAL MORTALITY (2022)
  • TABLE 220 GCC COUNTRIES: KEY MACROINDICATORS
  • TABLE 221 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 226 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MEDICAL HUMIDIFIERS MARKET PLAYERS, JANUARY 2022-FEBRUARY 2025
  • TABLE 227 MEDICAL HUMIDIFIER MARKET: DEGREE OF COMPETITION
  • TABLE 228 MEDICAL HUMIDIFIER MARKET: REGION FOOTPRINT
  • TABLE 229 MEDICAL HUMIDIFIER MARKET: PRODUCT FOOTPRINT
  • TABLE 230 MEDICAL HUMIDIFIER MARKET: APPLICATION FOOTPRINT
  • TABLE 231 MEDICAL HUMIDIFIER MARKET: END-USER FOOTPRINT
  • TABLE 232 MEDICAL HUMIDIFIER MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 233 MEDICAL HUMIDIFIER MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 234 MEDICAL HUMIDIFIER MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-FEBRUARY 2025
  • TABLE 235 MEDICAL HUMIDIFIER MARKET: DEALS, JANUARY 2022-FEBRUARY 2025
  • TABLE 236 MEDICAL HUMIDIFIER MARKET: EXPANSIONS, JANUARY 2022-FEBRUARY 2025
  • TABLE 237 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
  • TABLE 238 FISHER & PAYKEL HEALTHCARE LIMITED: CURRENCY CONVERSION
  • TABLE 239 FISHER & PAYKEL HEALTHCARE LIMITED.: PRODUCTS OFFERED
  • TABLE 240 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2022-JANUARY 2025
  • TABLE 241 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS, JANUARY 2022-JANUARY 2025
  • TABLE 242 RESMED INC.: COMPANY OVERVIEW
  • TABLE 243 RESMED INC.: PRODUCTS OFFERED
  • TABLE 244 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 245 DRAGERWERK AG & CO. KGAA: CURRENCY CONVERSION
  • TABLE 246 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
  • TABLE 247 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 248 KONINKLIJKE PHILIPS N.V.: CURRENCY CONVERSION (EURO TO USD)
  • TABLE 249 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 250 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY OVERVIEW
  • TABLE 251 VINCENT MEDICAL HOLDINGS LIMITED: CURRENCY CONVERSION (EURO TO USD)
  • TABLE 252 VINCENT MEDICAL HOLDINGS LIMITED: PRODUCTS OFFERED
  • TABLE 253 VINCENT MEDICAL HOLDINGS LIMITED: EXPANSIONS, JANUARY 2022-JANUARY 2025
  • TABLE 254 MEDLINE INDUSTRIES, LP.: COMPANY OVERVIEW
  • TABLE 255 MEDLINE INDUSTRIES, LP.: PRODUCTS OFFERED
  • TABLE 256 MEDLINE INDUSTRIES, LP.: DEALS, JANUARY 2022-JANUARY 2025
  • TABLE 257 MEDLINE INDUSTRIES, LP.: EXPANSIONS, JANUARY 2022-JANUARY 2025
  • TABLE 258 HAMILTON MEDICAL: COMPANY OVERVIEW
  • TABLE 259 HAMILTON MEDICAL: PRODUCTS OFFERED
  • TABLE 260 HAMILTON MEDICAL: EXPANSIONS, JANUARY 2022-JANUARY 2025
  • TABLE 261 GALEMED CORPORATION: COMPANY OVERVIEW
  • TABLE 262 GALEMED CORPORATION: PRODUCTS OFFERED
  • TABLE 263 GALEMED CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-JANUARY 2025
  • TABLE 264 EAKIN HEALTHCARE: COMPANY OVERVIEW
  • TABLE 265 EAKIN HEALTHCARE: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 MEDICAL HUMIDIFIER MARKET: RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION
  • FIGURE 8 MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 MEDICAL HUMIDIFIER MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL HUMIDIFIER MARKET
  • FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET
  • FIGURE 15 INTENSIVE CARE UNITS ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 16 CHINA TO RECORD HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 19 MEDICAL HUMIDIFIER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 MEDICAL HUMIDIFIER MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 MEDICAL HUMIDIFIER MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 22 MEDICAL HUMIDIFIER MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 MEDICAL HUMIDIFIER MARKET: PATENT ANALYSIS, JANUARY 2015-DECEMBER 2024
  • FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 25 MEDICAL HUMIDIFIER MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER
  • FIGURE 27 KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER
  • FIGURE 28 MEDICAL HUMIDIFIER MARKET: INVESTMENT & FUNDING SCENARIO 2022-2024
  • FIGURE 29 US: NUMBER OF RESPIRATORY THERAPISTS
  • FIGURE 30 US: TRENDS IN COPD, BY AGE
  • FIGURE 31 US: PRETERM BIRTH RATE, 2018-2023
  • FIGURE 32 UK AND IRELAND: ADMISSIONS TO PEDIATRIC INTENSIVE CARE UNITS, 2020-2022
  • FIGURE 33 NORTH AMERICA: MEDICAL HUMIDIFIER MARKET SNAPSHOT
  • FIGURE 34 US: INFANT MORTALITY RATE (2021 & 2022)
  • FIGURE 35 CANADA: DEATHS RELATED TO RESPIRATORY DISORDERS (2019-2023)
  • FIGURE 36 GERMANY: TRENDS IN UNDER-FIVE MORTALITY RATE
  • FIGURE 37 SPAIN: TRENDS IN UNDER-FIVE MORTALITY RATE (2018-2023)
  • FIGURE 38 ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET SNAPSHOT
  • FIGURE 39 JAPAN: MORTALITY RATE IN UNDER-FIVE AGE GROUP
  • FIGURE 40 INDIA: INCIDENCE OF TRACHEA, BRONCHUS, AND LUNG CANCER, BY AGE GROUP (2022 & 2045)
  • FIGURE 41 AUSTRALIA: PREVALENCE OF COPD, BY AGE GROUP (2001-2022)
  • FIGURE 42 AUSTRALIA: TRENDS OVER TIME FOR COPD HOSPITALIZATIONS AMONG PEOPLE AGED 45+ YEARS (2015-16 TO 2021-22)
  • FIGURE 43 GCC COUNTRIES: AGE DEMOGRAPHICS, BY COUNTRY (2023)
  • FIGURE 44 MEDICAL HUMIDIFIER MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2021-2023 (USD BILLION)
  • FIGURE 45 MEDICAL HUMIDIFIER MARKET SHARE ANALYSIS, 2023
  • FIGURE 46 RANKING OF KEY PLAYERS IN MEDICAL HUMIDIFIER MARKET, 2023
  • FIGURE 47 HEATED HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023)
  • FIGURE 48 HEAT & MOISTURE EXCHANGERS MARKET SHARE, BY KEY PLAYER (2023)
  • FIGURE 49 BUBBLE HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023)
  • FIGURE 50 MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 51 MEDICAL HUMIDIFIER MARKET: COMPANY FOOTPRINT
  • FIGURE 52 MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 EV/EBITDA OF KEY VENDORS
  • FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 MEDICAL HUMIDIFIER MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 56 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
  • FIGURE 57 RESMED INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 58 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 59 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY SNAPSHOT (2023)